• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

M-AMSA in disseminated prostatic carcinoma: a phase II study.

作者信息

Drelichman A, Decker D A, Al-Sarraf M, Dhabuwala C B

出版信息

Cancer Treat Rep. 1982 Nov;66(11):1993-4.

PMID:6897206
Abstract
摘要

相似文献

1
M-AMSA in disseminated prostatic carcinoma: a phase II study.
Cancer Treat Rep. 1982 Nov;66(11):1993-4.
2
Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
Cancer Treat Rep. 1983 Apr;67(4):391-2.
3
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):1009-10.
4
Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study.
Cancer Treat Rep. 1982 Aug;66(8):1651-2.
5
Phase II trial of AMSA in prostatic cancer.AMSA用于前列腺癌的II期试验。
Cancer Treat Rep. 1982 Jan;66(1):208-9.
6
A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
Cancer Clin Trials. 1981 Fall;4(3):249-51.
7
Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.高剂量安吖啶（AMSA）与自体骨髓移植用于难治性转移性乳腺癌患者的II期研究。
Cancer Treat Rep. 1983 Jun;67(6):599-600.
8
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1149-50.
9
Treatment of advanced colorectal carcinoma with AMSA.
Cancer Treat Rep. 1981 Mar-Apr;65(3-4):345-7.
10
Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.4'-(9-吖啶基氨基)甲磺基间茴香胺（AMSA）在非小细胞肺癌患者中的II期评估。
Cancer Treat Rep. 1980 Feb-Mar;64(2-3):345-7.

引用本文的文献

1
Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino] -4-acridinecarboxamide in rabbits.抗癌药物安吖啶与一种新类似物N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺在兔体内的药代动力学及蛋白结合率比较
Cancer Chemother Pharmacol. 1986;16(3):253-6. doi: 10.1007/BF00293987.
2
Dose-dependent pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in rabbits.
Cancer Chemother Pharmacol. 1987;20(1):13-5. doi: 10.1007/BF00252952.
3
The clinical pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4 -acridinecarboxamide (CI-921) in a phase 1 trial.N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺（CI-921）在1期试验中的临床药代动力学
Cancer Chemother Pharmacol. 1988;22(3):235-40. doi: 10.1007/BF00273417.
4
The effect of cimetidine, phenobarbitone and buthionine sulphoximine on the disposition of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in the rabbit.
Cancer Chemother Pharmacol. 1989;23(5):291-5. doi: 10.1007/BF00292406.